Target intelligence / Profile preview

VTCN1 pseudogene 1 (VTCN1P1)

Target
VTCN1P1
Molecular classification
Other (Pseudogene)
01

Overview

VTCN1 pseudogene 1 is a noncoding genetic element related to the VTCN1 gene, located on chromosome 20[5][7]. Pseudogenes arise from duplication or retrotransposition events and typically lack the ability to encode a functional protein. VTCN1P1 does not serve as a receptor, enzyme, or any type of molecular target in standard biological or pharmacological contexts, and has no documented functional or disease relevance[5]. Most biomedical research and therapeutic applications refer to the functional parent gene, **VTCN1 (V-set domain containing T cell activation inhibitor 1, also known as B7-H4, B7S1, B7X)**, which is an immune checkpoint molecule involved in modulating T cell activation and implicated in cancer progression[1][4][6][7][9][10]. There is no evidence supporting VTCN1P1 as a therapeutic target or biomarker. If structured information for a pharmacological target is needed, reference should be made to the functional **VTCN1 (B7-H4)** gene rather than its pseudogene VTCN1P1[1][4][6][7][9][10].

Other names
VTCN1 Pseudogene 1

Beyond the preview

Go deeper on VTCN1 pseudogene 1 (VTCN1P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on VTCN1 pseudogene 1 (VTCN1P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call